Ryan Specialty Holdings RYAN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.48B+13.2% | $1.58B-5.7% | $1.37B+1.3% | $1.52B-12.9% | $1.31B-19.1% | ||
| $565.26M+30.7% | $488.95M+25.4% | $439.8M+31.4% | $528.56M+37.5% | $432.48M+44.6% | ||
| $5.58B+21.0% | $5.06B+5.7% | $4.45B+10.6% | $5.27B+2.8% | $4.61B+9.3% | ||
| $66.14M+9.5% | $69.46M+38.3% | $69.79M+52.7% | $66.45M+46.0% | $60.4M+41.5% | ||
| $3.22B+6.4% | $3.23B+21.9% | $3.13B+33.7% | $3.09B+70.0% | $3.02B+83.6% | ||
| $127.05M+29.7% | $119.62M+43.0% | $110.98M+60.4% | $101.73M+86.8% | $97.99M+118% | ||
| $5.43B+2.9% | $5.5B+13.2% | $5.41B+21.2% | $5.36B+70.1% | $5.28B+82.1% | ||
| $11.01B+11.3% | $10.56B+9.5% | $9.85B+16.2% | $10.63B+28.4% | $9.89B+39.0% | ||
| $341.74M+73.3% | $284.4M+14.1% | $257.49M+24.9% | $195.68M+13.9% | $197.18M-14.5% | ||
| $35.36M-2.3% | $60.19M+16.3% | $41.81M+25.5% | $61.69M+87.0% | $36.21M-8.0% | ||
| $5.46B+24.0% | $5.19B+14.1% | $4.46B+12.4% | $5.23B+11.4% | $4.4B+19.6% | ||
| $3.57B-2.3% | $3.35B+2.1% | $3.39B+28.1% | $3.41B+75.7% | $3.65B+88.0% | ||
| $4.34B-2.2% | $4.12B+3.0% | $4.16B+22.0% | $4.21B+68.2% | $4.43B+79.9% | ||
| $9.79B+10.9% | $9.31B+8.9% | $8.62B+16.8% | $9.44B+31.2% | $8.83B+43.8% | ||
| $120.53M+51.9% | $120.35M-2.1% | $128.85M+3.1% | $115.35M-5.1% | $79.34M-10.4% | ||
| $636.2M+17.3% | $648.07M+3.3% | $630.47M-0.4% | $610.09M+0.7% | $542.52M-2.1% | ||
| $11.01B+11.3% | $10.56B+9.5% | $9.85B+16.2% | $10.63B+28.4% | $9.89B+39.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Ryan Specialty Holdings cover its short-term obligations?
- Its current ratio is 1.02 — current assets exceed current liabilities.
- Where does Ryan Specialty Holdings's balance sheet data come from?
- Every line is extracted from Ryan Specialty Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.